Itamar Medical Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Itamar Medical Ltd. generated cash of -$8,818,000, which is less than the previous year. Cash used in financing activities reached the amount of $35,458,000 last year. Net change in cash is therefore -$5,445,000.
Cash Flow
| 2012 | -1.72M | 2.25M | -4.60M |
|---|---|---|---|
| 2013 | -4.76M | -6.22M | 16.03M |
| 2014 | -5.44M | -3.17M | 6.93M |
| 2015 | -8.61M | 5.47M | 26.84M |
| 2016 | -10.63M | -568K | 1.1M |
| 2017 | -6.18M | -318K | -10.32M |
| 2018 | -3.88M | 2.79M | -85K |
| 2019 | 0 | -615K | 13.29M |
| 2020 | -8.81M | -32.28M | 35.45M |
ITMR Cash Flow Statement (2012 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 15.11M | 0 | 7.64M | 23.35M | 33.01M | 9.41M | 11.95M | 6.26M | 10.19M |
Operating activities | |||||||||
Net income | -10.93M | -5.26M | -1.72M | -5.30M | -14.40M | -2.24M | -3.27M | -12.91M | 517K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 1.81M | 1.28M | 481K | 509K | 434K | 367K | 324K | 400K | 330K |
Stock-based compensation expense | 1.49M | 0 | 1.02M | 1.29M | 1.77M | 428K | 1.47M | 143K | 408K |
| Deferred income tax benefit | 1.49M | 0 | 1.02M | 1.29M | 1.77M | 428K | 1.47M | 143K | 408K |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -548K | -2.09M | -1.06M | -833K | -1.54M | -1.30M | -1.17M | 609K | -83K |
Inventories | -4.54M | -339K | -340K | -711K | -430K | -268K | -445K | 526K | -484K |
Accounts payable | 2.14M | 537K | 237K | -66K | 289K | 5K | 432K | -155K | 52K |
Cash generated by operating activities | -8.81M | 0 | -3.88M | -6.18M | -10.63M | -8.61M | -5.44M | -4.76M | -1.72M |
Investing activities | |||||||||
Purchases Of Investments | -30M | 0 | 0 | 0 | 0 | 0 | -3.03M | -9.10M | -620K |
Investments In Property Plant And Equipment | -2.23M | -547K | -310K | -296K | -455K | -562K | -202K | -104K | -102K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -32.28M | -615K | 2.79M | -318K | -568K | 5.47M | -3.17M | -6.22M | 2.25M |
Financing activities | |||||||||
Common Stock Issued | 35.90M | 0 | 5.20M | 0 | 998K | 23.15M | 11.78M | 4.18M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -913K | 0 | -10.37M | 0 | 0 | 0 | -5.15M | -8.47M | -6.50M |
Cash used in financing activities | 35.45M | 13.29M | -85K | -10.32M | 1.1M | 26.84M | 6.93M | 16.03M | -4.60M |
Net Change In Cash | -5.44M | 12.67M | -1.17M | -15.71M | -9.66M | 23.60M | -2.53M | 5.68M | -3.93M |
Cash at end of period | 9.67M | 12.67M | 6.47M | 7.64M | 23.35M | 33.01M | 9.41M | 11.95M | 6.26M |